Table 1 Patients characteristics
Number of patients | n = 30 |
|---|---|
Years of age -- median (range) | 64 (47-78) |
Estrogen-receptor status -- no. (%) | |
Positive | 26 (87%) |
Negative | 4 (13%) |
Progesterone-receptor status -- no. (%) | |
Positive | 18 (60%) |
Negative | 12 (40%) |
HER2 status -- no. (%) | |
Positive | 0 (0%) |
Negative | 30 (100%) |
Previous adjuvant chemotherapy -- no. (%) | |
None | 3 (10%) |
Anthracycline | 15 (50%) |
Anthracycline + Taxane | 8 (27%) |
Vinorelbine | 1 (3%) |
Disease-free interval -- no. (%) | |
≤ 24 mo | 7 (23%) |
> 24 mo | 23 (77%) |
Extent of disease -- no. (%) | |
≥ 3 sites | 22 (73%) |
< 3 sites | 8 (27%) |
Location of disease -- no. (%) | |
Visceral | 21 (70.%) |
Non Visceral | 9 (30.%) |
ECOG Status | |
0 | 7 (23%) |
1 | 22 (73%) |